safety of glp-1 receptor agonists Frontiers New MHRA warning on the

The only way to know which alternative works best for your specific biology is systematic trial at therapeutic doses with adequate time for evaluation

Besides, GLP-1 receptors are also expressed in the human choroid plexus, and the GLP-1-RA exenatide was reported to reduce intracranial pressure in a rodent model as well as in a pilot study on 15 pwIIH [14, 15]

Basic Res Cardiol 2016

However, ICV administration of higher doses of GLP- 1 (1 and 3 nmol) and GIP (6 nmol) significantly reduced food intake and body weight

[DOI] [PubMed] [Google Scholar] 73.McCormick LM, Heck PM, Ring LS, Kydd AC, Clarke SJ, Hoole SP, et al

I.TahraniA